MedTrace Logo

Simvatstatin Used to Treat Pulmonary Hypertension

NCT00538044 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2007-10-02

No results posted yet for this study

Summary

we try to use simvastatin in the treatment of advanced pulmoary hypertension secondary to congenital heart disease or chronic pulmonary embolism before and after the operation.

Conditions

  • Hypertension, Pulmonary

Interventions

DRUG

simvastatin

medication with simvastation on the dosage of 40mg per day before the operation and all the time after the operation

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Huili Gan, MD,Ph.D. · Beijing Anzehn Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Completion
2012-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00538044 on ClinicalTrials.gov